Abstract
In press
Background. Type 1 Diabetes Mellitus (T1DM) in children is associated with a high risk of microvascular complications, with Diabetic Nephropathy (DN) being a leading cause of disability. The prevalence of DN necessitates the search for new modifiable risk factors. The role of vitamin D deficiency as a predictor of progression to albuminuria in children with a T1DM duration exceeding 5 years requires further investigation.
Aim. To evaluate the prognostic value of 25‑hydroxyvitamin D levels in the development of DN in children and adolescents with T1DM (disease duration >5 years) and to compare vitamin D status in patients with normo- and albuminuria.
Materials and Methods. A total of 50 patients aged 6–17 years with a T1DM duration of over 5 years were examined. The participants were divided into two groups: Group 1 (normoalbuminuria, n=26) and Group 2 (albuminuria, n=24). Serum 25‑hydroxyvitamin D (25(OH)D) levels were measured using the ELISA method. Renal function was assessed by the albumin-to-creatinine ratio and the estimated Glomerular Filtration Rate (eGFR) using the Schwartz formula (2009). Statistical analysis was performed using Statistica 13.3 (TIBCO Software Inc., USA) with the application of the Shapiro–Wilk test, Mann–Whitney U test, Spearman's rank correlation coefficient, and binary logistic regression. The study was conducted within the framework of a research project with state registration number 0123U101768.
Research Ethics. The study was conducted in accordance with the World Medical Association Declaration of Helsinki (1964–2024) and Order No.690 of September 23, 2009, of the Ministry of Health of Ukraine. Written informed consent was obtained from the parents of all participants.
Results. 25(OH)D levels in patients of Group 2 were significantly lower than in Group 1: 15.83 (12.22; 21.52) ng/mL vs. 22.03 (17.23; 24.04) ng/mL (p=0.009). Vitamin D deficiency was significantly more prevalent in Group 2 (75.0% vs. 42.3%, p=0.0223). Children with albuminuria and hypovitaminosis were more likely to exhibit hyperfiltration (29.2%) and a decrease in eGFR <90 mL/min/1.73 m² (41.6%). A decrease in vitamin D levels <20 ng/mL increases the odds of DN development by 3.49 times (OR=3.49; 95% CI [1.53–7.95]), independent of glycated hemoglobin levels and T1DM duration.
Conclusions. Vitamin D deficiency is an independent predictor of DN development in children with long-standing T1DM. Low 25(OH)D levels are associated with impaired renal filtration and the progression of albuminuria.
Keywords: pediatrics and neonatology, type 1 diabetes mellitus, vitamin D, albuminuria, children and adolescents.
References
Gregory GA, Robinson TI, Linklater SE, Wang F, Colagiuri S, de Beaufort C, Donaghue KC; International Diabetes Federation Diabetes Atlas Type 1 Diabetes in Adults Special Interest Group, et al. Global incidence, prevalence, and mortality of type 1 diabetes in 2022 with 2040 projections: data-modelling study. The Lancet Diabetes & Endocrinology. 2022;10(10):741-60. DOI: 10.1016/S2213-8587(22)00218-2. PMID: 36113507.
Ruiz-Grao MC, Díez-Fernández A, Mesas AE, Martínez-Vizcaíno V, Sequí-Domínguez I, Sebastián-Valles F, Garrido-Miguel M. Trends in the Incidence of Type 1 Diabetes in European Children and Adolescents from 1994 to 2022: A Systematic Review and Meta-Analysis. Pediatr Diabetes. 2024;2024:2338922. DOI: 10.1155/2024/2338922. PMID: 40302967.
Lin X, Xu Y, Pan X, Xu J, Ding Y, Sun X, et al. Global, regional, and national burden and trend of diabetes in 195 countries and territories: an analysis from 1990 to 2025. Sci Rep. 2020;10(1):14790. DOI: 10.1038/s41598-020-71908-9. PMID: 32901098.
Ezzatvar Y, Hormazábal-Aguayo I, Muñoz-Pardeza J, Páez-Herrera J, Yáñez-Sepúlveda R, García-Hermoso A. Global Prevalence of Microvascular Complications in Children and Adolescents With Type 1 and Type 2 Diabetes: A Systematic Review and Meta-Analysis. Pediatr Diabetes. 2025;2025:8398194. DOI: 10.1155/pedi/8398194. PMID: 41346657.
Wang H, Yuan T, Wu W, Ou S. Vitamin D and chronic kidney disease: mechanisms, clinical implications, and future perspectives. Front Med (Lausanne). 2025:12:1643415. DOI: 10.3389/fmed.2025.1643415. PMID: 41164167.
Li YC. Vitamin D and the renin-angiotensin system. In: Feldman D, editor. Vitamin D. 4th ed. Academic Press; 2018. P. 825-47. DOI: 10.1016/B978-0-12-809965-0.00045-8.
Chackochan A, Rashid M, Reghunath SR, Poojari PG, Thunga G, Nagri SK, et al. Role of vitamin D in the development and progression of diabetic kidney disease: an overview of meta-analyses. Ther Adv Endocrinol Metab. 2025;16:20420188251319476. DOI: 10.1177/20420188251319476. PMID: 40297636.
Zhang X, Zhang L, Wen Y, Zhang M, Liu S, Xiao H. Vitamin D Ameliorates Podocyte Injury by Enhancing Autophagy Activity in Diabetic Kidney Disease. Kidney Blood Press Res. 2023;48(1):314-25. DOI: 10.1159/000530403. PMID: 37054686.
Barot KS, Abbasi ZA, Krishna Mohan GV, Abid SA, Hussain SA, Wei CR, Ali N. Prevalence of Vitamin D Deficiency in Children and Adolescents with Type 1 Diabetes Mellitus: A Systematic Review and Meta-Analysis. Cureus. 2025;17(5):e83843. DOI: 10.7759/cureus.83843. PMID: 40491630.
Liu C, Wang J, Wan Y, Xia X, Pan J, Gu W, Li M. Serum vitamin D deficiency in children and adolescents is associated with type 1 diabetes mellitus. Endocr Connect. 2018;7(12):1275-9. DOI: 10.1530/EC-18-0191. PMID: 30352405.
Almansour S, Alsalamah A, Almutlaq M, Sheikh A, Hamdan HZ, Al-Nafeesah A, et. al. Association of vitamin D deficiency and insufficiency with uncontrolled type 1 diabetes Mellitus among Saudi pediatric patients; a hospital-based retrospective study. Front Pediatr. 2025;12:1479815. DOI: 10.3389/fped.2024.1479815. PMID: 39845452.
Gao J, Song X, Ou H, Cheng X, Zhang L, Liu C, et. al. The association between vitamin D and the progression of diabetic nephropathy: insights into potential mechanisms. Front Med (Lausanne). 2024;11:1388074. DOI: 10.3389/fmed.2024.1388074. PMID: 38978780.
Alicic RZ, Rooney MT, Tuttle KR. Diabetic Kidney Disease: Challenges, Progress, and Possibilities. Clin J Am Soc Nephrol. 2017;12(12):2032-45. DOI: 10.2215/CJN.11491116. PMID: 28522654.
Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int. 2024;105(4S):117-314. DOI: 10.1016/j.kint.2023.10.018. PMID: 38490803.
Bjornstad P, Dart A, Donaghue KC, Dost A, Feldman EL, Tan GS, et. al. ISPAD Clinical Practice Consensus Guidelines 2022: Microvascular and macrovascular complications in children and adolescents with diabetes. Pediatr Diabetes. 2022;23(8):1432-50. DOI: 10.1111/pedi.13444. PMID: 36537531.
American Diabetes Association Professional Practice Committee. 11. Chronic Kidney Disease and Risk Management: Standards of Care in Diabetes-2024. Diabetes Care. 2024;47(Suppl_1):S219-30. DOI: 10.2337/dc24-S011. PMID: 38078574.
Munns CF, Shaw N, Kiely M, Specker BL, Thacher TD, Ozono K, et al. Global consensus recommendations on prevention and management of nutritional rickets. Horm Res Paediatr. 2016;85(2):83-106. DOI: 10.1159/000443136. PMID: 26743929.
Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, et al.; Endocrine Society. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. The Journal of Clinical Endocrinology & Metabolism. 2011;96(7):1911-1930. DOI: 10.1210/jc.2011-0385. PMID: 21646368.
Demay MB, Pittas AG, Bikle DD, Diab DL, Kiely ME, Lazaretti-Castro M, et al. Vitamin D for the Prevention of Disease: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2024;109(8):1907-47. DOI: 10.1210/clinem/dgae290. Erratum in: J Clin Endocrinol Metab. 2025;110(3):e916. DOI: 10.1210/clinem/dgae854. Erratum in: J Clin Endocrinol Metab. 2025;110(8):e2810. DOI: 10.1210/clinem/dgaf310. PMID: 38828931.
Chackochan A, Rashid M, Reghunath SR, Poojari PG, Thunga G, Nagri SK, Guddattu V, et al. Role of vitamin D in the development and progression of diabetic kidney disease: an overview of meta-analyses. Ther Adv Endocrinol Metab. 2025;16:20420188251319476. DOI: 10.1177/20420188251319476. PMID: 40297636.
Huang B, Wen W, Ye S. Correlation between serum 25-hydroxyvitamin D levels in albuminuria progression of diabetic kidney disease and underlying mechanisms by bioinformatics analysis. Front Endocrinol (Lausanne). 2022;13:880930. DOI: 10.3389/fendo.2022.880930. PMID: 35634488.
Emini Sadiku M. Impact of vitamin D and vitamin D receptor activator in diabetic nephropathy. Front Clin Diabetes Healthc. 2025;6:1537336. DOI: 10.3389/fcdhc.2025.1537336. PMID: 40134933.
Huang HY, Lin TW, Hong ZX, Lim LM. Vitamin D and Diabetic Kidney Disease. Int J Mol Sci. 2023;24(4):3751. DOI: 10.3390/ijms24043751. PMID: 36835159.
Chen Z, Malek V, Natarajan R. Update: the role of epigenetics in the metabolic memory of diabetic complications. Am J Physiol Renal Physiol. 2024;327(3):F327-39. DOI: 10.1152/ajprenal.00115.2024. PMID: 38961840.

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
